In Short
S&S Co. coordinates corporate, commercial litigation and IP matters in Hyderabad through representative counsel, with oversight from our Noida and Kolkata partners, connecting clients to the Telangana High Court and NCLT Hyderabad Bench.
Serving Hyderabad's Pharma, IT & Life Sciences Sector
Hyderabad has emerged as a major hub for pharmaceuticals, biotechnology, life sciences and information technology, anchored by HITEC City and Genome Valley, alongside the Telangana High Court and the NCLT's Hyderabad Bench.
For clients with Hyderabad-connected matters, S&S Co. coordinates through representative counsel, with our partners overseeing corporate advisory, IP protection relevant to the pharma and life sciences sector, and commercial litigation strategy.
Nearby Courts & Tribunals
Telangana High Court
NCLT — Hyderabad Bench
City Civil Court, Hyderabad — Commercial Court
DRT / DRAT — Hyderabad
Telangana RERA
Trade Marks Registry — Chennai (Hyderabad jurisdiction)
Practice Areas Served in Hyderabad
How We Serve Hyderabad Clients
Hyderabad matters are coordinated through representative counsel connected to the Telangana High Court and NCLT Hyderabad Bench, with strategic oversight from our Noida and Kolkata partners.
Illustrative Scenarios
The following are hypothetical, illustrative scenarios prepared for educational purposes. They are not descriptions of actual client matters, and no outcome is guaranteed in any specific case.
Illustrative Scenario
Pharmaceutical Company Defending a Patent Opposition
A Hyderabad-based pharmaceutical company faces a pre-grant opposition to its patent application from a generic manufacturer. Demonstrating a genuine inventive step beyond prior art is central to defending the application before the Patent Office.
Illustrative Scenario
Life Sciences Company Structuring a Licensing Agreement
A Hyderabad life sciences company wants to license its formulation technology to an international partner. A carefully structured licensing agreement addressing territory, royalty and IP ownership avoids disputes as the relationship develops.
Illustrative Scenario
IT Company Navigating a Data Protection Compliance Review
A Hyderabad IT company serving international clients needs to align its data handling practices with evolving data protection requirements. A structured compliance review helps avoid contractual and regulatory exposure with overseas clients.
Illustrative Scenario
Genome Valley Company Structuring an Investment Round
A Hyderabad biotech company in Genome Valley closing its first institutional investment round needs shareholder protections that don't compromise founder control. Getting this balance right at the first round matters for future fundraising.
Notable Legal Developments
Delhi High Court2026
ADS Spirits v. Registrar of Trade Marks
'Uniqueness' Is Not the Test for Trademark Registration — Distinctiveness Under Section 9(1)(a) Suffices
The Delhi High Court held that a mark need not be wholly unique to qualify for registration under Section 9(1)(a) of the Trade Marks Act, 1999 — distinctiveness in relation to the goods or services concerned is the governing standard. The Court also directed the Trade Marks Registry to pass reasoned, speaking orders when refusing applications rather than terse rejections.
Key Takeaway — Applicants wrongly refused registration on grounds of 'lack of uniqueness' now have clear Delhi HC authority to challenge such orders, and are entitled to a reasoned order explaining the refusal.
Joint Parliamentary Committee — Bill PendingApr 2026
Corporate Laws (Amendment) Bill, 2026
Corporate Laws (Amendment) Bill 2026 Set to Overhaul NCLT Scheme-of-Arrangement Procedure
Now before the Joint Parliamentary Committee, the Bill proposes sweeping changes to Sections 230–233 of the Companies Act, 2013, streamlining NCLT scheme-of-arrangement procedures, revising creditor/shareholder meeting-class thresholds, clarifying cross-border merger rules for foreign companies, decriminalising a swathe of provisions, and removing the IBC cross-reference from Section 230(1). Multi-bench NCLT schemes that previously took 12–14 months are expected to complete materially faster once the reforms are notified.
Key Takeaway — Deal teams should build the Bill's phased notification timeline into scheme-of-arrangement planning now — CP language and expected timelines in transaction documents may need revision once provisions come into force.
See all Legal Updates →
Frequently Asked Questions
Does S&S Co. have an office in Hyderabad?
We coordinate Hyderabad-connected matters through representative counsel, with strategic oversight from our Noida and Kolkata partners, rather than a dedicated branch office.
Can S&S Co. advise pharma or life sciences companies in Hyderabad?
Yes — our IP and corporate practices regularly advise on patent, regulatory and corporate matters relevant to the pharmaceutical and life sciences sector.
Does S&S Co. handle NCLT matters in Hyderabad?
Yes, through representative counsel connected to the NCLT Hyderabad Bench.